EGF-related peptides and their receptors in mammary gland development

Journal of Mammary Gland Biology and Neoplasia

Volumn 2, Issue 2, 1997, Pages 109-117

  DiAugustine, Richard P ^a   Richards, R Gregg ^a   Sebastian, Joseph ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

EGF receptor; EGF like growth factors; erbB receptors; Estradiol; Lactation; Mammary gland development; Tyrosine phosphorylation; Waved 2 mutant mouse

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LIGAND; PROTEIN TYROSINE KINASE;

ANIMAL; FEMALE; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW; UDDER;

ANIMALS; EPIDERMAL GROWTH FACTOR; FEMALE; LIGANDS; MAMMARY GLANDS, ANIMAL; MICE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 0031107241     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026395513038     Document Type: Article

References (56)

1. G. Carpenter and M. I. Wahl (1991). The epidermal growth factor family. In M. B. Sporn and A. B. Roberts (eds.), Peptide Growth Factors and Their Receptors I, Springer-Verlag, New York, pp. 69-171.
2. K. L. Carraway, C. A. C. Carraway, and K. L. Carraway, III (1997). Roles of ErbB-3 and ErbB-4 in physiology and pathology of the mammary gland. J. Mam. Gland Biol. Neoplasia 2(2):187-198.
3. R. Pinkas-Kramarski, I. Alroy, and Y. Yarden (1997). ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling. J. Mam. Gland Biol. Neoplasia 2(2):97-107.
4. Y. Taketani and T. Oka (1983). Possible physiological role of epidermal growth factor in the development of the mouse mammary gland during pregnancy. FEBS Lett. 152:256-261.
5. Y. Taketani and T. Oka (1983). Biological action of epidermal growth factor and its functional receptors in normal mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 80:2647-2650.
6. Q. J. Tonelli and S. Sorof (1980). Epidermal growth factor requirement for development of cultured mammary gland. Nature 285:250-252.
7. S. Nandi (1958). Endocrine control of mammary gland development and function in the C3H/HeCrg 1 mouse. J. Natl. Cancer Inst. 21:1039-1063.
8. W. R. Lyons, C. H. Li, and R. E. Johnson (1958). The hormonal control of mammary growth and lactation. Recent Prog. Horm. Res. 14:219-250.
9. C. W. Daniel, G. B. Silberstein, and P. Strickland (1988). Direct action of 17β-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res. 47:6052-6057.
10. G. B. Silberstein, K. Van Horn, G. Shyamala, and C. W. Daniel (1994). Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. Endocrinology 134:84-90.
11. S. C. Liu, B. Sanfilippo, I. Perroteau, R. Derynck, D. S. Salomon, and W. R. Kidwell (1987). Expression of transforming growth factor α (TGFα) in differentiated rat mammary tumors: Estrogen induction of TGFα production. Mol. Endocrinol. 1:683-692.
12. S. E. Bates, N. E. Davidson, E. M. Valverius, C. E. Freter, R. B. Dickson, J. P. Tam, J. E. Kudlow, M. E. Lippman, and D. S. Salomon (1988). Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: Its regulation by estrogen and its possible functional significance. Mol. Endocrinol. 2:543-555.
13. T. Saeki, A. Cristiano, M. J. Lynch, M. Brattain, N. Kim, N. Normanno, N. Kenny, F. Ciardiello, and D. S. Salomon (1991). Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene. Mol. Endocrinol. 5:1955-1963.
14. R. B. Dickson and M. E. Lippman (1995). Growth factors in breast cancer. Endocrine Rev. 16:559-589.
15. S. Coleman, G. B. Silberstein and C. W. Daniel (1988). Ductal morphogenensis in the mouse mammary gland: Evidence supporting a role for epidermal growth factor. Develop. Biol. 127:304-315.
16. S. M. Snedeker, C. F. Brown, and R. P. DiAugustine (1992). Expression and functional properties of transforming growth factor α and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 88:276-280.
17. S. Z. Haslam, L. J. Counterman, and K. A. Nummy (1993). Effects of epidermal growth factor, estrogen, and progestin on DNA synthesis in mammary cells in vivo are determined by the developmental state of the gland. J. Cell. Physiol. 155:72-78.
18. G. B. Silberstein and C. W. Daniel (1987). Investigation of mouse mammary ductal growth regulation using slow-release plastic implants. J. Dairy Sci. 70:1981-1990.
19. S. Coleman and C. W. Daniel (1990). Inhibition of mouse mammary ductal morphogenesis and down-regulation of the EGF receptor by epidermal growth factor. Develop. Biol. 137:425-433.
20. S. Z. Haslam, L. J. Counterman, and K. A. Nummy (1992). EGF receptor regulation in normal mouse mammary gland. J. Cell. Physiol. 152:553-557.
21. A. Gompel, A. Martin, P. Simon, D. Schoevaert, G. Plu-Bureau, D. Hugol, J. Audouin, E. Leygue, J. B. Truc, and Ph. Poitout (1996). Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle. Breast Cancer Res. Treat. 38:227-235.
22. E. D. Adamson, M. J. Deller, and J. B. Warshaw (1981). Functional EGF receptors are present on mouse embryo tissues. Nature 291:656-659.
23. E. D. Adamson and J. B. Warshaw (1982). Down-regulation of epidermal growth factor receptors in mouse embryos. Develop. Biol. 90:430-434.
24. F. E. Jones, D. J. Jerry, B. C. Guarino, G. C. Andrews, and D. F. Stern (1996). Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Diff. 7:1031-1038.
25. E. Peles, S. S. Bacus, R. A. Koski, H. S. Lu, D. Wen, S. G. Ogden, R. Ben Levy, Y. Yarden (1992). Isolation of the neu/ HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell 69:205-216.
26. S. S. Bacus, E. Huberman, D. Chin, K. Kiguchi, S. Simpson, M. Lippman, and R. Lupu (1992). A ligand for the erbB-2 oncogene product (gp 30) induces differentiation of human breast cancer cells. Cell Growth Diff. 3:401-411.
27. Y. Taketani and T. Oka (1983). Epidermal growth factor stimulates cell proliferation and inhibits functional differentiation of mouse mammary epithelial cells in culture. Endocrinology 113:871-877.
28. C. Q. Lin, P. J. Dempsey, R. J. Coffey, and M. J. Bissell (1995). Extracellular matrix regulates whey acidic protein gene expression by suppression of TGF-a in mouse mammary epithelial cells: Studies in culture and in transgenic mice. J. Cell Biol. 129:1115-1126.
29. L. B. Rail, J. Scott, G. I. Bell, R. J. Crawford, J. D. Penschow, H. D. Niall, and J. P. Coghlan (1985). Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 313:228-231.
30. C. F. Brown, C. T. Teng, B. T. Pentecost, R. P. DiAugustine (1989). Epidermal growth factor precursor in mouse lactating mammary gland alveolar cells. Mol. Endocrinol. 3:1077-1083.
31. S. E. Fenton and L. G. Sheffield (1991). Lacotogenic hormones increase epidermal growth factor messenger RNA content of mouse mammary glands. Biochem. Biophy. Res. Comm. 181:1063-1069.
32. G. D. Jahnke, J. Chao, M. P. Walker, and R. P. DiAugustine (1994). Detection of a kallikrein in the mouse lactating mammary gland: A possible processing enzyme for the epidermal growth factor precursor. Endocrinology 135:2022-2029.
33. G. Carpenter (1980). Epidermal growth factor is a major growth promoting agent in human milk. Science 210:198-199.
34. O. Koldovsky (1996). The potential physiological significance of milk-borne hormonally active substances for the neonate. J. Mam. Gland Biol. Neoplasia 1:317-323.
35. D. S. Liscia, G. Merlo, F. Ciardiello, N. Kim, G. H. Smith, R. Callahan, and D. S. Salomon (1990). Transforming growth factor-α messenger RNA localization in the developing adult rat and human mammary gland by in situ hybridization. Develop. Biol. 140:123-131.
36. J. A. Smith, R. Barraclough, D. G. Fernig, and P. S. Rudland (1989). Identification of alpha transforming growth factor as a possible local trophic agent for the mammary gland. J. Cell. Physiol. 141:326-370.
37. P. W. Cook, P. A. Mattox, W. W. Keeble, M. R. Pittelkow, G. D. Plowman, M. Shoyab, J. P. Adelman, and G. D. Shipley (1991). A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol. Cell. Biol. 11:2547-2557.
38. S. Li, G. D. Plowman, S. D. Buckley, and G. D. Shipley (1992). Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells. J. Cell. Physiol. 153:103-111.
39. N. J. Kenney, G. H. Smith, I. G. Maroulakou, J. H. Green, W. J. Muller, R. Callahan, D. S. Salomon, and R. B. Dickson (1996). Detection of amphiregulin and cripto-1 in mammary tumors from transgenic mice. Mol. Carcin. 15:44-56.
40. N. J. Kenney, R.-P. Huang, G. Johnson, J.-X. Wu, D. Okamura, W. Matheny, E. Kordon, W. J. Gullick, G. Plowman, G. H. Smith, D. S, Salomon, and E. D. Adamson (1995), Detection and location of amphiregulin and cripto-1 expression in the developing postnatal mouse mammary gland. Mol. Reprod. Dev. 41:277-286.
41. Y. Yang, E. Spitzer, D. Meyer, M. Sachs, C. Niemann, G. Hartmann, K. M. Weidner, C. Birchmeier, and W. Birchmeier (1995). Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 131:215-226.
42. S. A. Prigent, N. R. Lemoine, C. M. Hughes, G. D. Plowman, C. Selden, and W. J. Gullick (1992). Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene 7:1273-1278.
43. Z. Sheng, K. Wu, K. L. Carraway, and N. Fregien (1992). Molecular cloning of the transmembrane component of the 13762 mammary adenocarcinoma sialomucin complex. A new member of the epidermal growth factor superfamily. J. Biol. Chem. 267:16341-16346.
44. neu. Oncogene 9:3139-3147.
45. K. S. Korach (1994). Insights from the study of animals lacking functional estrogen receptor. Science 266:1524-1527.
46. J. P. Lydon, F. J. DeMayo, O. M. Conneely, and B. W. O'Malley (1996). Reproductive phenotypes of the progesterone receptor null mutant mouse. J. Steroid Biochem. Molec. Biol. 56:67-77.
47. N. C. Luetteke, H. K. Phillips, T. H. Qiu, N. G. Copeland, H. S. Earp, N. A. Jenkins, and D. C. Lee (1994). The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Develop. 8:399-413.
48. K. J. Fowler, F. Walker, W. Alexander, M. L. Hibbs, E. C. Nice, R. M. Bohmer, G. B. Mann, C. Thumwood, R. Maglitto, J. A. Danks, R. Chetty, A. W. Burgess, and A. R. Dunn (1995). A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. U.S.A. 92:1465-1469.
49. G. B. Mann, K. J. Fowler, A. Gabriel, E. C. Nice, R. L. Williams, and A. R. Dunn (1993). Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73:249-261.
50. N. C. Luetteke, T. H. Qiu, R. L. Peiffer, P. Oliver, O. Smithies, and D. C. Lee (1993). TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73:263-278.
51. L. T. Amundadottir, G. Merlino, and R. B. Dickson (1996). Transgenic mouse models of breast cancer. Breast Cancer Res. Treat. 39:119-135.
52. R. D. Cardiff (1996). The biology of mammary transgenes: Five rules. J. Mam. Gland Biol. Neoplasia 1:61-73.
53. R. G. Richards, R. P. DiAugustine, P. Petrusz, G. C. Clark, and J. Sebastian (1996). Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus. Proc. Natl. Acad. Sci. U.S.A. 93:12002-12007.
54. neu protein and EGF receptor modulates EGF receptor function. Cell 61:1339-1347.
55. R. Goldman, R. Ben-Levy, E. Peles, and Y. Yarden (1990). Heterodimerization of the erbB-1 and ErbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochem. 29:11024-11028.
56. P. Ordronneau, P. B.-M. Lindstrom, and P. Petrusz (1981). Four unlabeled antibody bridge techniques: a comparison. J. Histochem. Cytochem. 29:1397-1404.